List of Tables
Table 1. Acute Myeloid Leukemia Drugs Market Trends
Table 2. Acute Myeloid Leukemia Drugs Market Drivers & Opportunity
Table 3. Acute Myeloid Leukemia Drugs Market Challenges
Table 4. Acute Myeloid Leukemia Drugs Market Restraints
Table 5. Global Acute Myeloid Leukemia Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Acute Myeloid Leukemia Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Acute Myeloid Leukemia Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Acute Myeloid Leukemia Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Acute Myeloid Leukemia Drugs Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Acute Myeloid Leukemia Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Acute Myeloid Leukemia Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Acute Myeloid Leukemia Drugs
Table 13. Global Acute Myeloid Leukemia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Acute Myeloid Leukemia Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Acute Myeloid Leukemia Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Acute Myeloid Leukemia Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Acute Myeloid Leukemia Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Acute Myeloid Leukemia Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Acute Myeloid Leukemia Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Acute Myeloid Leukemia Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Acute Myeloid Leukemia Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Acute Myeloid Leukemia Drugs Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Acute Myeloid Leukemia Drugs Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Acute Myeloid Leukemia Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Acute Myeloid Leukemia Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Acute Myeloid Leukemia Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Acute Myeloid Leukemia Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Acute Myeloid Leukemia Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Acute Myeloid Leukemia Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Acute Myeloid Leukemia Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Acute Myeloid Leukemia Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Acute Myeloid Leukemia Drugs Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Acute Myeloid Leukemia Drugs Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Acute Myeloid Leukemia Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Acute Myeloid Leukemia Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Acute Myeloid Leukemia Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Acute Myeloid Leukemia Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Acute Myeloid Leukemia Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Acute Myeloid Leukemia Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Acute Myeloid Leukemia Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Acute Myeloid Leukemia Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Acute Myeloid Leukemia Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Acute Myeloid Leukemia Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Acute Myeloid Leukemia Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Acute Myeloid Leukemia Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Acute Myeloid Leukemia Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Acute Myeloid Leukemia Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Acute Myeloid Leukemia Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Acute Myeloid Leukemia Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Acute Myeloid Leukemia Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Ambit Biosciences Corporation Company Information
Table 58. Ambit Biosciences Corporation Introduction and Business Overview
Table 59. Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Product Offerings
Table 61. Ambit Biosciences Corporation Recent Development
Table 62. Bristol Myers Squibb Company Information
Table 63. Bristol Myers Squibb Introduction and Business Overview
Table 64. Bristol Myers Squibb Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Bristol Myers Squibb Acute Myeloid Leukemia Drugs Product Offerings
Table 66. Bristol Myers Squibb Recent Development
Table 67. Cephalon Company Information
Table 68. Cephalon Introduction and Business Overview
Table 69. Cephalon Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Cephalon Acute Myeloid Leukemia Drugs Product Offerings
Table 71. Cephalon Recent Development
Table 72. Clavis Pharma Company Information
Table 73. Clavis Pharma Introduction and Business Overview
Table 74. Clavis Pharma Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Clavis Pharma Acute Myeloid Leukemia Drugs Product Offerings
Table 76. Clavis Pharma Recent Development
Table 77. Eisai Company Information
Table 78. Eisai Introduction and Business Overview
Table 79. Eisai Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Eisai Acute Myeloid Leukemia Drugs Product Offerings
Table 81. Eisai Recent Development
Table 82. Genzyme Corporation Company Information
Table 83. Genzyme Corporation Introduction and Business Overview
Table 84. Genzyme Corporation Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Genzyme Corporation Acute Myeloid Leukemia Drugs Product Offerings
Table 86. Genzyme Corporation Recent Development
Table 87. Sunesis Pharmaceuticals Company Information
Table 88. Sunesis Pharmaceuticals Introduction and Business Overview
Table 89. Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Product Offerings
Table 91. Sunesis Pharmaceuticals Recent Development
Table 92. Novartis Company Information
Table 93. Novartis Introduction and Business Overview
Table 94. Novartis Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Novartis Acute Myeloid Leukemia Drugs Product Offerings
Table 96. Novartis Recent Development
Table 97. Eli Lilly and Company Company Information
Table 98. Eli Lilly and Company Introduction and Business Overview
Table 99. Eli Lilly and Company Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Eli Lilly and Company Acute Myeloid Leukemia Drugs Product Offerings
Table 101. Eli Lilly and Company Recent Development
Table 102. Otsuka Holdings Company Information
Table 103. Otsuka Holdings Introduction and Business Overview
Table 104. Otsuka Holdings Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Otsuka Holdings Acute Myeloid Leukemia Drugs Product Offerings
Table 106. Otsuka Holdings Recent Development
Table 107. Takeda Pharmaceuticals Company Information
Table 108. Takeda Pharmaceuticals Introduction and Business Overview
Table 109. Takeda Pharmaceuticals Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Takeda Pharmaceuticals Acute Myeloid Leukemia Drugs Product Offerings
Table 111. Takeda Pharmaceuticals Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Acute Myeloid Leukemia Drugs Downstream Customers
Table 115. Acute Myeloid Leukemia Drugs Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Acute Myeloid Leukemia Drugs Product Picture
Figure 2. Global Acute Myeloid Leukemia Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Acute Myeloid Leukemia Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Acute Myeloid Leukemia Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Acute Myeloid Leukemia Drugs Sales Price (2019-2030) & (USD/Unit)
Figure 6. Acute Myeloid Leukemia Drugs Report Years Considered
Figure 7. Global Acute Myeloid Leukemia Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Acute Myeloid Leukemia Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Acute Myeloid Leukemia Drugs Revenue in 2023
Figure 10. Acute Myeloid Leukemia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Chemotherapy Picture
Figure 12. Targeted Therapy Picture
Figure 13. Other Picture
Figure 14. Global Acute Myeloid Leukemia Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Acute Myeloid Leukemia Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Acute Myeloid Leukemia Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Acute Myeloid Leukemia Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Acute Myeloid Leukemia Drugs Price by Type (2019-2030) & (USD/Unit)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Clinic
Figure 21. Product Picture of Others
Figure 22. Global Acute Myeloid Leukemia Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Acute Myeloid Leukemia Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Acute Myeloid Leukemia Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Acute Myeloid Leukemia Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Acute Myeloid Leukemia Drugs Price by Application (2019-2030) & (USD/Unit)
Figure 27. North America Acute Myeloid Leukemia Drugs Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Acute Myeloid Leukemia Drugs Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Acute Myeloid Leukemia Drugs Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Acute Myeloid Leukemia Drugs Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Acute Myeloid Leukemia Drugs Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Acute Myeloid Leukemia Drugs Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Acute Myeloid Leukemia Drugs Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Acute Myeloid Leukemia Drugs Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Acute Myeloid Leukemia Drugs Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Acute Myeloid Leukemia Drugs Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Acute Myeloid Leukemia Drugs Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Acute Myeloid Leukemia Drugs Sales Volume (%), (2019-2030)
Figure 39. United States Acute Myeloid Leukemia Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Acute Myeloid Leukemia Drugs Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Acute Myeloid Leukemia Drugs Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Acute Myeloid Leukemia Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Acute Myeloid Leukemia Drugs Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Acute Myeloid Leukemia Drugs Sales Value by Application (%), 2023 VS 2030
Figure 45. China Acute Myeloid Leukemia Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Acute Myeloid Leukemia Drugs Sales Value by Type (%), 2023 VS 2030
Figure 47. China Acute Myeloid Leukemia Drugs Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Acute Myeloid Leukemia Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Acute Myeloid Leukemia Drugs Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Acute Myeloid Leukemia Drugs Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Acute Myeloid Leukemia Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Acute Myeloid Leukemia Drugs Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Acute Myeloid Leukemia Drugs Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Acute Myeloid Leukemia Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Acute Myeloid Leukemia Drugs Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Acute Myeloid Leukemia Drugs Sales Value by Application (%), 2023 VS 2030
Figure 57. India Acute Myeloid Leukemia Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Acute Myeloid Leukemia Drugs Sales Value by Type (%), 2023 VS 2030
Figure 59. India Acute Myeloid Leukemia Drugs Sales Value by Application (%), 2023 VS 2030
Figure 60. Acute Myeloid Leukemia Drugs Industrial Chain
Figure 61. Acute Myeloid Leukemia Drugs Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
